While investors and executives in the health care products industry have not remained untouched by the COVID-19 pandemic, they have not been as surprised as people might assume about the situation that global economies now find themselves in, with the second or even third waves of coronavirus in full flow.
That is how Nooman Haque, managing director, life sciences and healthcare at Silicon Valley Bank (SVB), has viewed the 11 months since the pandemic put a stop to normal social...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?